BioLife Solutions (BLFS) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $38.61 --0%
Revenue Growth %: +3.9%
Financial Fact:
Total operating expenses: 2.35M
Today's EPS Names:
XFOR, MG, YORW, More
Revenue Growth %: +3.9%
Financial Fact:
Total operating expenses: 2.35M
Today's EPS Names:
XFOR, MG, YORW, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q2 EPS of ($0.11), $0.02 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $2 million versus the consensus estimate of $2.01 million.
BioLife Solutions reaffirmed FY2016 guidance.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ACM Research (ACMR) Tops Q3 EPS by 6c ; Offers Guidance
- Air Products (APD) Reports In-Line Q4 EPS ; Offers Guidance
- Lincoln National (LNC) Tops Q3 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
